RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.

In a report released on January 29, Jack Lynch from RBC Capital maintained a Hold rating on HUB24 Limited (FSB – Research Report), with a price ...

US stocks slipped on Friday afternoon, with carmakers and Chinese companies leading the decline, as the White House said ...

Brian McGill and Michael Hyser operate as Johns Creek Financial along with support-staff members Stacie Alexander and Alexis ...

UBS analyst Susy Tibaldi updated the financial outlook for EssilorLuxottica SA (EL:FP) (OTC: OTC:ESLOY), increasing the price ...

Australian shares are poised to rise with inflation data awaited. Boeing surged, Nvidia rebounded and Apple extended its recovery. Follow updates here.

Bonnici was a managing director at RBC and led several high-profile deals across infrastructure and technology during his ...

RBC Capital Markets increased its price target on Celestica (NYSE:CLS) shares from $115.00 to $140.00 while maintaining an Outperform rating. Currently trading at $131.66, near its 52-week high, ...

UBS upgraded British American Tobacco on Monday ... to buy the shares and make it a more attractive "pure-play", RBC Capital Markets said in a note on Monday. WH Smith confirmed earlier that ...

On Thursday, RBC Capital Markets adjusted its outlook on shares ... driven by expected higher revenues and share buybacks. UBS increased their price target for JPMorgan shares to $287 from the ...

Analyst firms such as UBS, RBC Capital Markets, Citi, Mizuho Securities USA, and Stephens have all adjusted their ratings and price targets for Expand Energy, reflecting the company's strategic ...